REG - FranklinResourcesInc Medtronic, Inc. - Form 8.3 - Medtronic Inc. <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 0147WFranklin Resources, Inc03 November 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1967,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
Franklin Resources, Inc.
Company dealt in
Medtronic Inc.
Class of relevant security to which the dealings being disclosed relate (Note 2)
Ordinary Shares
Date of dealing
31 October 2014
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
44,614,414 4.54%
16,462 0.002%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
44,614,414 4.54%
16,462 0.002%
(b) Interests and short positions in relevant securities of the company, other than the class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
(a) Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 5)
Purchase
30
68.1000 USD
Sale
1,680
67.9500 USD
(b) Derivatives transactions (other than options transactions)
Product name,
e.g. CFD
Nature of transaction (Note 6)
Number of relevant securities (Note 7)
Price per unit (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None stated.
Is a Supplemental Form 8 attached?(Note 9) NO
Date of disclosure
3 November 2014
Contact name
Jean V. Brown
Telephone number
+1 (954) 847-2443
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEZXLFBZFFZFBX
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement